The struggle to recapture the Italian peninsula from Axis forces has sometimes been overshadowed by other World War II ...

Bombardamento dell’Abbazia di Montecassino, il racconto di Aldo Cazzullo: "Il bombardamento dell’Abbazia di Montecassino si rivela un errore clamoroso. Nel monastero non c’è traccia di tedeschi, i ...

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG ...

È un 60enne di Cassino l'uomo “agganciato” e scaraventato a terra dal treno in transito ieri sera sulla tratta Napoli - Roma, a ridosso della stazione ferroviaria di Cassino. È ricoverato ...

DOMENICA: un campo di alte pressioni abbraccia la Regione garantendo tempo stabile ed assolato ovunque. Nello specifico sui litorali settentrionali cieli in prevalenza sereni o poco nuvolosi per l ...

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...

Since the beginning of the phenomenon readers now know as the Lightlark series, Alex Aster has understood how her story ends. But the question of when that ending should arrive—and how her ...

Partly cloudy with a high of 62 °F (16.7 °C). Winds NE at 6 to 8 mph (9.7 to 12.9 kph). Night - Cloudy with a 48% chance of precipitation. Winds from NE to NNE at 6 to 7 mph (9.7 to 11.3 kph ...

Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using ...

Oct 28 (Reuters) - Swiss pharmaceutical giant Novartis (NOVN.S), opens new tab will pay Monte Rosa Therapeutics (GLUE.O), opens new tab $150 million upfront payment for a global license to develop ...

DOMENICA: un campo di alte pressioni abbraccia la Regione garantendo tempo stabile ed assolato ovunque. Nello specifico su Daunia, murge, Tavoliere, litorale adriatico settentrionale, litorale ...

Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...